Td Asset Management Inc Dyne Therapeutics, Inc. Transaction History
Td Asset Management Inc
- $114 Billion
- Q3 2025
A detailed history of Td Asset Management Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 20,382 shares of DYN stock, worth $383,996. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,382Holding current value
$383,996% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding DYN
# of Institutions
220Shares Held
130MCall Options Held
36.5KPut Options Held
138K-
Vanguard Group Inc Valley Forge, PA9.76MShares$184 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$183 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$178 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$172 Million26.07% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$139 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $975M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...